Amniotic Fluid and the Fetal Mucosal Immune System

Stella Nowicki, Randall M. Goldblum

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Amniotic fluid is frequently sampled by amniocentesis for genetic analysis of the fetus between 10. weeks and the end of the first half of pregnancy. Amniotic fluid plays a role in defense of the fetal and uterine structures against infection, signaling the uterus that the fetus has sustained an infection, initiating parturition, and/or modulating the maternal immune response to prevent rejection of the fetus. The number of potential sites for secretion of various constituents into the amniotic fluid is expanded after organogenesis. The cytokines and prostaglandins in the amniotic fluid might impact the development of the immune system of the fetus. Some antiretroviral drugs are able to cross the placenta and are concentrated in the amniotic fluid. This chapter summarizes immune factors that participate in the innate immune system during pregnancy.

Original languageEnglish (US)
Title of host publicationMucosal Immunology: Fourth Edition
PublisherElsevier Inc.
Pages2251-2268
Number of pages18
Volume2-2
ISBN (Print)9780124159754, 9780124158474
DOIs
StatePublished - Apr 1 2015

    Fingerprint

Keywords

  • African American
  • Amniotic fluid
  • Antiretroviral
  • Complement
  • Cytokines
  • Fetus
  • Gestational age
  • Immunoglobulin
  • Placenta
  • Preterm delivery

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Nowicki, S., & Goldblum, R. M. (2015). Amniotic Fluid and the Fetal Mucosal Immune System. In Mucosal Immunology: Fourth Edition (Vol. 2-2, pp. 2251-2268). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-415847-4.00115-4